We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Pancreatic Pseudocyst Drainage With a Metal Stent

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01239056
Recruitment Status : Completed
First Posted : November 11, 2010
Results First Posted : August 21, 2015
Last Update Posted : September 7, 2015
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose of this study is to study the evaluation of the effectiveness of endoscopic Pancreatic Pseudocyst drainage using a metal stent.

Condition or disease Intervention/treatment
Pancreatic Pseudocysts Procedure: Endoscopy

Study Design

Study Type : Observational
Actual Enrollment : 22 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Prospective Evaluation of the Clinical Utility of Pseudocyst Drainage With Metal Stent
Study Start Date : August 2009
Primary Completion Date : May 2015
Study Completion Date : May 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Endoscopy
U.S. FDA Resources

Groups and Cohorts

Group/Cohort Intervention/treatment
Pancreatic Pseudocysts
All adult patients who have a clinical indication to undergo an endoscopic drainage of a pancreatic pseudocyst.
Procedure: Endoscopy
Endoscopic drainage of a pancreatic pseudocyst using a metal stent per medical indication.


Outcome Measures

Primary Outcome Measures :
  1. Technical Success of Endoscopic Ultrasound-guided Single-access Pseudocyst Drainage With a Fully Covered Self-expanding Metal Stent ; Anchored With a Double Pigtail Plastic Stent Inserted Through the Metal Stent Lumen [ Time Frame: baseline ]

    Technical success was evaluated by the ability to achieved pseudocyst drainage after endoscopically placing a Fully Covered Self-expanding Metal Stent in the pseudocyst .

    Technical failure was evaluated by the inability to fully drain the pancreas pseudocyst after endoscopically placing a Fully Covered Self-expanding Mental Stent in the pseudocyst.



Secondary Outcome Measures :
  1. Resolution of Pancreatic Pseudocyst After Placement of Fully Covered Self-expanding Metal Stent (CSEMS). [ Time Frame: 6 to 12 weeks after baseline ]
  2. Adverse Events [ Time Frame: 1 year ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients who have a medical indication for endoscopic drainage of pancreatic pseudocyst and are referred for the procedure as part of their standard medical care will be considered for the study.
Criteria

Inclusion Criteria:

  1. Subject is 18 years or older
  2. Subject has pancreatic pseudocyst
  3. Subject has medical indication for drainage of the pancreatic pseudocyst
  4. Subject must be able to give informed consent

Exclusion Criteria:

  1. Any contraindication to endoscopic pseudocyst drainage
  2. Subject is unable to give informed consent
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01239056


Locations
United States, Florida
Shands UF Endoscopy
Gainesville, Florida, United States, 32608
Sponsors and Collaborators
University of Florida
Investigators
Principal Investigator: Peter V draganov, MD University of Florida
More Information

Responsible Party: University of Florida
ClinicalTrials.gov Identifier: NCT01239056     History of Changes
Other Study ID Numbers: Pancreatic Pseudocyst
First Posted: November 11, 2010    Key Record Dates
Results First Posted: August 21, 2015
Last Update Posted: September 7, 2015
Last Verified: August 2015

Additional relevant MeSH terms:
Pancreatic Pseudocyst
Pancreatic Cyst
Cysts
Neoplasms
Pancreatic Diseases
Digestive System Diseases